We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Matthew
Harding
ppip@psych.ox.ac.uk
Dr
Belinda
Lennox
belinda.lennox@psych.ox.ac.uk
Ms
Ksenija
Yeeles
ppip@psych.ox.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Schizophrenia, schizotypal and delusional disorders
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The PPiP study aims to understand if some cases of psychosis are caused by immune system problems in some people.
The immune system normally controls our ability to fight infection. If the immune system goes wrong it may cause diseases called ‘autoimmune’ diseases. We can diagnose some of these autoimmune diseases using blood tests. We are specifically interested in antibodies affecting the N-methyl D-aspartate receptors (NMDA-r) or other neuronal membrane targets that may be the cause symptoms of psychosis and possibly cause some cases of schizophrenia. We are working with Early Intervention in Psychosis (EIP) services across England to estimate the prevalence of these autoimmune diseases in people with first episode psychosis.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cohort study;
You can take part if:
You may not be able to take part if:
Any other neurological disorders including multiple sclerosis, epilepsy, cerebrovascular disease, hydrocephalus, traumatic brain injury, meningo-encephalitis, systemic lupus erythematosus, CNS vasculitis. Primary drug induced psychosis.
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Belinda
Lennox
belinda.lennox@psych.ox.ac.uk
Ms
Ksenija
Yeeles
ppip@psych.ox.ac.uk
Matthew
Harding
ppip@psych.ox.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Oxford and funded by Medical Research Council (MRC) .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 18451
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
